Business Wire1mon
World’s First Drug Candidate developed by Organoid and AI Doses First Patient in Phase 1 Study for first Diffusive Gastric Cancer Targeted Therapy
This marks a significant milestone as SIGX1094 is the first pipeline drug discovered using AI and organoid disease model to enter clinical trials, and the first targeted therapy candidate to ...
Google’s new AI co-scientist aims to speed up the scientific discovery process
Google has unveiled an AI co-scientist built on its Gemini 2.0 platform, aiming to accelerate scientific research by ...
The Scientist11d
A Novel Three-in-One Pancreatic Organoid
An innovative organoid model mirrors the pancreas' complexity, generating all three key cell types to explore development and ...
World’s First Potential Target Therapy for Diffuse Gastric Cancer Granted Fast Track Designation by the U.S. FDA
Signet Therapeutics, a clinical-stage biotech company leveraging organoid- and AI-driven cancer drug discovery, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...
technologynetworks15d
Organoids, Beyond the Hype
The HUMANOID Center at UC San Diego is pioneering organoid research aimed at improving the reliability and reproducibility of ...
News Medical4d
The impact of cytokines on stem cells and organoid research in drug discovery
Source: Sino Biological Inc. Organoid platforms, together with cytokine-driven differentiation protocols, enable high-throughput drug screening. For example, liver organoids supported by VEGF and ...
News Medical3d
Human organoids for AAV capsid selection
Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...
ascopubs.org4d
Efficacy and safety of organoid-based drug sensitivity screening to guide the treatment of mCRPC patients progressed after first-line treatment.
The effect of circadian rhythm–based medication timing adjustments on the efficacy and safety of novel hormonal therapy. Phase III, double-blind, placebo-controlled, 2-cohort, randomized study of ...
Patient-specific brain tumor models guide personalized treatment
Scientists from the German Cancer Research Center (DKFZ) and ShanghaiTech University have developed an innovative method for ...
Scientists Reprogram Immune Cells to Stop Autoimmune Attacks
A revolutionary approach to immune therapy has emerged: engineered immune cells that protect healthy tissue without ...
Business Wire1d
World’s First Potential Target Therapy for Diffuse Gastric Cancer Granted Fast Track Designation by the U.S. FDA
BOSTON & SHENZHEN, China--(BUSINESS WIRE)--Signet Therapeutics, a clinical-stage biotech company leveraging organoid- and AI-driven cancer drug discovery, announced that the U.S. Food and Drug ...